What This Treatment Is
Suboxone is a brand-name combination of buprenorphine (a partial opioid agonist) and naloxone (an opioid antagonist included to deter misuse). It’s FDA-approved for the treatment of opioid use disorder, delivered as a sublingual film or tablet that dissolves under the tongue. When taken as prescribed, buprenorphine reduces cravings and withdrawal without producing the euphoria associated with opioid misuse.
Why the Buprenorphine/Naloxone Combination
Buprenorphine on its own is effective. The naloxone component doesn’t do much when the medication is taken correctly (dissolved under the tongue), because naloxone isn’t well absorbed that way. But if someone tries to inject Suboxone, the naloxone activates and blocks the buprenorphine’s effect. That structural discouragement of misuse is why the combination exists.
Who Suboxone Is For
Suboxone is appropriate for adults with opioid use disorder — whether the opioid history involves prescription pain medications, heroin, or fentanyl. It’s typically prescribed inside a treatment structure that includes counseling and behavioral therapy, per SAMHSA guidance.
Our Care Model: Specialty-Led, Distinct Primary Tracks
Elevated Healing operates separate primary treatment tracks for Mental Health and Substance Use, each led by the appropriate clinical specialty from day one. When both are present, our teams coordinate care across tracks so the full clinical picture is addressed without collapsing treatment into a single generalized program.
This is different from a blended or generalized model. Read more on our Care Model page.
Elevated Healing’s Specialty-Led Approach
Suboxone at our Woodland Hills campus is prescribed by board-certified psychiatric providers with experience in addiction medicine. Induction — the first few days of medication — is planned carefully: buprenorphine cannot be started while the patient is still fully opioid-dependent without risking precipitated withdrawal. Timing matters, and we walk each patient through it.
Once induction is complete:
- Dose is titrated to the individual — typically 8 to 24 mg daily, adjusted based on cravings, withdrawal, and side effects.
- Follow-up visits are weekly at first, then biweekly, then monthly as stability increases.
- Concurrent therapy (CBT, DBT, EMDR, or ART) is delivered on-site or via telehealth.
- Random toxicology testing is used clinically — not punitively — to guide treatment decisions.
Access at Our Woodland Hills Campus
Our campus is at 21250 Califa St, Ste 114, Woodland Hills, CA 91367, in the West San Fernando Valley. Access is straightforward:
- From the 101 (Ventura Freeway) — exit at De Soto Avenue or Winnetka Avenue and drive a short distance north.
- From the 118 (Ronald Reagan Freeway) — take Winnetka or De Soto south into the West Valley.
- Nearby communities — Warner Center, Winnetka, West Hills, Canoga Park, Tarzana, and Encino are all a short drive.
- Telehealth — after your initial in-person assessment, most follow-up psychiatric visits can be done by video for California residents.
Parking and check-in details are provided at intake. If accessibility accommodations are needed, tell our admissions team when you call.
Program Levels That Deliver This Care
This service is delivered inside the level of care that matches your clinical need at intake. Level of care can shift over time as treatment progresses.
Partial Hospitalization (PHP)
Structured day program, five days per week, with psychiatric oversight and integrated therapy.
Learn about PHPIntensive Outpatient (IOP)
Three-to-five sessions per week that allow work or school to continue.
Learn about IOPOutpatient (OP)
Weekly therapy plus regular psychiatric visits — well-suited to step-down maintenance.
Learn about OPTelehealth Follow-Up
Video visits with the psychiatric provider, available across California for eligible patients.
Learn about telehealthInsurance, Cost, and Getting Started
Most commercial insurance plans cover suboxone treatment under mental health and substance use disorder benefits, which are subject to federal parity requirements under the Mental Health Parity and Addiction Equity Act. Parity means insurers cannot impose stricter limits on behavioral health services than they apply to physical health services — a real legal protection worth knowing you have when you call.
The first step is a conversation with our admissions team. This call is free, confidential, and carries no obligation. During it, we:
- Verify your insurance benefits within one business day.
- Confirm what’s covered, what your copay or coinsurance will be, and whether prior authorization applies.
- Start any required prior authorization on your behalf so you’re not stuck on hold with your insurer.
- Schedule a clinical evaluation — usually within a few business days of your first call, sooner when the situation is time-sensitive.
If insurance doesn’t cover the service or your plan design doesn’t fit, self-pay options can be discussed. There is no charge to have this conversation. Reach us at (747) 888-3000 or use our insurance verification form.
What Progress Looks Like
Recovery through suboxone treatment is not a straight line, and durable clinical outcomes rarely happen in weeks. Realistic timelines matter here more than optimistic promises. Most patients notice measurable improvement in the first month of consistent treatment — reduced cravings, more stable mood, better sleep, easier engagement with therapy. Substantive behavioral change typically takes root over three to six months.
Progress is reviewed at every clinical visit. We measure it in specifics: frequency of the target behavior, functional recovery in work and relationships, sleep quality, and — where medications are involved — how well the pharmacology is holding cravings and side effects. When something isn’t working, we adjust. That might mean a dose change, a therapy focus shift, or a step up or down in level of care. The plan follows the patient’s clinical picture, not the other way around.
Setbacks are treated as clinical data, not moral failure. If a relapse or symptom flare happens, the team’s job is to understand what led to it and refine the plan. Patients are not discharged for a relapse. Long-term recovery is often what happens after the acute treatment phase ends, and we plan for that from the first visit — through aftercare planning, coordinated hand-offs, and telehealth follow-up available across California.
Confidentiality and HIPAA Protections
Treatment records at Elevated Healing are protected under the Health Insurance Portability and Accountability Act (HIPAA) and, for substance use records specifically, under 42 CFR Part 2 — a federal regulation providing additional protection for substance use disorder treatment information. That means treatment status and clinical details are not disclosed to family members, employers, or third parties without your written authorization, except in narrowly defined legal circumstances (imminent harm, court order).
Practical protections include HIPAA-compliant scheduling and communication systems, secure insurance verification channels, and billing structured to minimize what appears on statements. Patients with heightened confidentiality concerns can request specific accommodations at intake — arrival timing, check-in flow, telehealth-first scheduling — and our admissions team will confirm what’s available.
Frequently Asked Questions
How is Suboxone different from methadone?
Will I feel high on Suboxone?
How long will I need to take Suboxone?
What if I have chronic pain?
Can I do Suboxone induction via telehealth?
Does insurance cover Suboxone treatment?
If You’re in Crisis
If you or someone you love is in immediate crisis, help is available 24/7. You are not alone.
- 988 Suicide & Crisis Lifeline — Call or text 988 (24/7, free, confidential)
- SAMHSA National Helpline — 1-800-662-HELP (4357) — mental health & substance use referrals
- The Trevor Project — 1-866-488-7386 — LGBTQ+ youth crisis support
Trusted External Resources
Independent, evidence-based sources on the topics covered on this page:
Federal public health agency’s overview of buprenorphine for opioid use disorder.
FDA drug information on buprenorphine and other opioid use disorder medications.
NIH institute publishing research on addiction neuroscience and treatment efficacy.
APA’s public-facing guidance on substance use disorders and treatment options.
CDC data and prevention resources for opioid overdose.
Ready to Talk About Suboxone Treatment?
Our admissions team can walk you through what treatment looks like, verify insurance benefits, and answer questions. Conversations are confidential.
Call us confidentially at (747) 888-3000 — or request a consultation online.
Schedule Your Consultation